Premium
Sinus Floor Elevation and Implant Placement via the Crestal and Lateral Approach in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Report of Two Cases
Author(s) -
Stasko Sasha B.,
Kolhatkar Shilpa,
Bhola Monish
Publication year - 2014
Publication title -
clinical advances in periodontics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.182
H-Index - 2
eISSN - 2163-0097
pISSN - 2573-8046
DOI - 10.1902/cap.2013.120092
Subject(s) - medicine , implant , dentistry , maxillary sinus , sinus (botany) , radiography , molar , maxilla , population , human immunodeficiency virus (hiv) , crown (dentistry) , orthodontics , surgery , botany , environmental health , biology , genus , family medicine
Implant placement in the posterior maxilla is frequently complicated by sinus proximity. Intraoral surgical procedures, including implant placement, have been described in patients with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS). Although reported widely in the general population, there is no description of implant placement with sinus floor augmentation (SFA) in these individuals. To the best of the authors’ knowledge, these are the first cases of SFA and implant placement via the crestal and lateral approaches in patients with HIV/AIDS. Case Presentation: A 50‐year‐old male presented for replacement of missing left maxillary first and second molars. Three‐dimensional radiography confirmed the presence of 3 to 5 mm of bone in the ideal implant positions. Lateral‐window SFA using a combination of particulate xenograft and allograft resulted in 10 mm of vertical height, allowing simultaneous placement of two implants. Restoration was completed after 6 months of healing. The second patient, a 40‐year‐old male, presented for replacement of a missing left maxillary first molar. Seven millimeters of native bone allowed a crestal approach for SFA. An oroantral communication was detected intraoperatively after several loads of bone graft had been added, and the decision was made to postpone implant placement. After 2.5 months, implant placement was completed, and the crown was delivered 6 months later. All implant‐retained restorations continue to function satisfactorily. Conclusions: Implant placement with SFA in well‐managed patients with HIV/AIDS is a viable treatment option. These case reports add to a growing body of evidence supporting the implementation of the full range of implant therapies in patients with HIV/AIDS.